Streetbeat News

Revenues

PEG

Public Service Enterprise (NYSE:PEG) reported Q1 2024 earnings of $1.31 per share, meeting analyst estimates. However, their quarterly sales of $2.760 billion fell short of the expected $3.065 billion, marking a 9.94% miss and a 26.50% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:32 am

LIND

Lindblad Expeditions projects its FY24 tour revenues to be in the range of $610M to $630M, compared to the estimated $620.27M.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:31 am

NVS

PeptiDream has expanded its peptide discovery collaboration with Novartis, receiving an upfront payment of $180M and eligibility for up to $2.71B in milestone payments. This expansion signifies a deepening of the partnership between the two companies, potentially leading to significant financial benefits for PeptiDream and advancements in peptide-based therapeutics.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:18 am

GRTS

Gritstone Bio presented data at ESCMID Global 2024 showcasing the durability and broad utility of its self-amplifying mRNA COVID-19 vaccine, indicating potential for widespread application and long-term effectiveness.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:16 am

HRMY

Harmony Biosciences acquires Epygenix Therapeutics for $35M, with potential development and sales milestone payments totaling $645M. EPX-100, their lead candidate for rare epilepsy conditions, is in a pivotal trial with topline data expected in 2026, indicating a significant market opportunity.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:14 am

CCJ

Cameco projects its 2024 consolidated revenue to be between C$2.9 billion and C$3.0 billion, slightly below the consensus of C$3.054 billion. The company also expects its share of Westinghouse's 2024 adjusted EBITDA to range from C$445 million to C$510 million, indicating a solid outlook and strong cash flow generation.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:13 am

DAN

Dana Incorporated has reaffirmed its FY24 sales guidance to be between $10.65B and $11.15B, closely aligning with the estimated $10.90B. The company also expects its FY24 diluted EPS to range from $0.35 to $0.85, with an adjusted EBITDA between $875M and $975M, indicating an implied adjusted EBITDA margin of approximately 8.5% at the midpoint of the range.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:11 am

PLBY

Playboy has announced the signing of multiple new license agreements in China, aiming to expand its brand presence and product offerings in the Chinese market. These agreements are expected to enhance Playboy's visibility and revenue potential in one of the world's largest consumer markets.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:08 am

OTLY

Oatly has reaffirmed its financial outlook for 2024, projecting a revenue growth of 5%-10% on a constant currency basis and an adjusted EBITDA loss of $35M-$60M.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:08 am

SCL

Stepan Company (SCL) anticipates full-year adjusted EBITDA growth and positive free cash flow, driven by recovery in Rigid Polyols, growth in Surfactant volumes, and an expected recovery in the Agricultural business in the second half of the year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 11:06 am